Ying Cai

Ying Cai currently serves as the Director of Clinical Supply Chain at Revolution Medicines since January 2024. Previously, Ying held the position of Director of Supply Chain at Ashvattha Therapeutics, Inc., managing end-to-end supply chain operations across five programs and successfully navigating numerous challenges to maintain GxP study timelines. Prior experience includes roles such as Associate Director of Global Supply Chain at Puma Biotechnology, Inc., where Ying oversaw clinical supply operations for 19 studies, and Sr. Clinical Supply Manager positions at MyoKardia and IGNYTA, Inc., managing clinical supply chains and achieving significant milestones, including 100% on-time availability for 23 studies. Ying holds multiple certifications from UC San Diego in Project Management Essentials and Good Manufacturing Practice (GMP).